Osteopore Ltd. (AU:OSX) has released an update.
Osteopore Ltd. has reported its 6th consecutive quarter of revenue growth with a significant 28% increase year-on-year and a 3% rise from the previous quarter. The company also successfully raised A$2.9 million through an Entitlement Offer, aiming to bolster its balance sheet and fund further sales, mergers, acquisitions, and research and development. Additionally, Osteopore has launched first-in-human clinical trials for knee preservation at the National University Hospital Singapore.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.
